安樂工程(01977.HK)建議出售南京佳力圖不超3%股份
格隆匯1月8日丨安樂工程(01977.HK)公佈,於本公吿日期,南京佳力圖為一間於上海證券交易所上市的公司且由公司擁有約25.44%權益。公司已知會南京佳力圖,其擬出售最多3%A股(即最多6,507,000股)。透過競價方式出售的期限為自本公吿日期起計上海證券交易所15個交易日後的6個月內。透過大宗交易方式出售的期限為自本公吿日期起計上海證券交易所3個交易日後的6個月內。
公司董事認為,建議出售事項(倘落實)為公司提供機會以合理價格變現其於南京佳力圖的投資的部分權益及分配資源以發展公司其他業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.